ANG Lifesciences India Limited

ANG6

INE236W01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:50 2024-04-26 am EDT			5-day change	1st Jan Change
57.2 ^INR	-0.33%		+0.37%	-17.59%

Feb. 14	ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	ANG Lifesciences India CFO Steps Down	MT

ANG Lifesciences India Limited Announces Resignation of Neeraj Gupta as Chief Financial Officer

October 14, 2023 at 08:41 am EDT

ANG Lifesciences India Limited announced that Mr. Neeraj Gupta has tendered his resignation from the post of Chief Financial Officer (KMP) of the company, effective October 14, 2023.

Latest news about ANG Lifesciences India Limited

ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
ANG Lifesciences India CFO Steps Down	23-10-15	MT
ANG Lifesciences India Limited Announces Resignation of Neeraj Gupta as Chief Financial Officer	23-10-14	CI
ANG Lifesciences India Limited Appoints Rohit Mittal as Additional Director (Non-Executive Non Independent Director)	23-10-11	CI
ANG Lifesciences India Limited Informs Mrs. Sudesh Kumari Resigns as Non-Executive Non Independent Director	23-10-11	CI
ANG Lifesciences India Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
ANG Lifesciences India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
ANG Lifesciences India Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
ANG Lifesciences India Limited Appoints Neeraj Gupta as the CFO	23-05-30	CI
ANG Lifesciences India Limited announced that it expects to receive INR 60.5 million in funding from ANG Capital Investments Private Limited	23-04-04	CI
ANG Lifesciences India Limited announced that it expects to receive INR 60.5 million in funding from ANG Capital Investments Private Limited	23-03-05	CI
ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
ANG Lifesciences India CFO Resigns	22-12-05	MT
ANG Lifesciences India Limited Announces Resignation of Subodh Sharma as Chief Financial Officer	22-12-05	CI
ANG Lifesciences India Limited announced that it expects to receive INR 20 million in funding	22-11-28	CI
ANG Lifesciences India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Infomerics Valuation Raises Rating on ANG Lifesciences India's Long-term Bank Financing; Outlook Stable	22-09-06	MT
ANG Lifesciences India Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-14	CI
ANG Lifesciences Gets BSE Nod for Bonus Issue of Shares	22-07-10	MT
ANG Lifesciences India Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-30	CI
ANG Lifesciences India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-30	CI
ANG Lifesciences Board to Consider Issuance of Bonus Shares; Shares Jump 5%	22-05-23	MT
ANG Lifesciences India Limited Approves Re-Constitution of Committee	22-03-29	CI
ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI

Chart ANG Lifesciences India Limited

Duration

Period

More charts

ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packagings. The Company's products portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. It is engaged in the business of manufacturing and sales of finished pharmaceutical formulations in a dosage form of Dry Powder Injection Vials, Liquid Injections Vials, Ampoules, PFS, Hard Gelatin Capsules, Tablets, Soft Gelatin Capsules, Dry Syrups, Liquid Syru ps and Suspension, and Lotions, among others. The Company's subsidiaries include ANG Lifesciences India Limited and Mansa Prints and Publishers Limited.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ANG LIFESCIENCES INDIA LIMITED	-17.59%	8.96M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B